Actelion Ltd. (JOBS) Latest Casualty as Roche (JOBS) Trims Portfolio; Roche Drops Actelion Study in Favor of Own Drug
Reuters -- Swiss drugmaker Roche Holding is ending a deal with biotech Actelion to develop a drug to treat autoimmune diseases, continuing a portfolio overhaul that began after its Genentech buy.